News & Analysis as of

Medi-Cal Drug Pricing

Sheppard Mullin Richter & Hampton LLP

Medi-Cal Rx: California to Transition Medi-Cal Pharmacy Benefits to Fee-For-Service

On April 1, 2021, the California Department of Health Care Services (“DHCS”) will be transitioning all Medi-Cal pharmacy benefits from managed care to fee-for-service (“FFS”). This new system to administer FFS pharmacy...more

Mintz - Health Care Viewpoints

March 2019: Where Are We Now With 340B?

Long time readers of our blog may recall that five years ago, I predicted that 2014 might be a game-changing year for the 340B Drug Discount Program. 2014 saw attempts at regulatory changes, but a successful court challenge...more

Manatt, Phelps & Phillips, LLP

Governor Newsom’s First State Budget: New Policy and Funding Priorities for California

This week, California’s newly inaugurated 40th governor, Gavin Newsom, unveiled his first state budget proposal, which projects nearly $6.1 billion in new revenues, would authorize $144.2 billion in state General Fund...more

Patrick Malone & Associates P.C. | DC Injury...

For Golden State, a $1 Billion Tab from Big Pharma to Treat One Disease

Californians have gotten an unpleasant taste of the policy complexities caused when Big Pharma sets sky-high prices for life-changing drugs: State health officials say they need to set aside $1 billion to pay for increasing...more

4 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide